Authors: Medhurst, AD Zeng, BY Charles, KJ Gray, J Reavill, C Hunter, AJ Shale, JA Jenner, P

Citation: Ad. Medhurst et al., Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-dopa treatment, NEUROSCIENC, 105(2), 2001, pp. 353-364

Authors: Zeng, BY Pearce, RKB MacKenzie, GM Jenner, P

Citation: By. Zeng et al., Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study, J NEURAL TR, 108(8-9), 2001, pp. 925-941

Authors: Zeng, BY Pearce, RKB MacKenzie, GM Jenner, P

Citation: By. Zeng et al., Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA, EUR J NEURO, 12(3), 2000, pp. 1096-1104

Authors: Jenner, P Zeng, BY Smith, LA Pearce, RKB Tel, B Chancharme, L Moachon, G

Citation: P. Jenner et al., Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset, EXP BRAIN R, 133(2), 2000, pp. 178-188

Authors: Zeng, BY Dass, B Owen, A Rose, S Cannizzaro, C Tel, BC Jenner, P

Citation: By. Zeng et al., Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned rats, NEUROSCI L, 276(2), 1999, pp. 71-74